Abvc Biopharma (ABVC) Convertible Debt (2018 - 2024)
Abvc Biopharma's (ABVC) quarterly Convertible Debt came in at $872336.0 in Q1 2024, up 2661.69% YoY from $31587.0 in Q2 2023, and down 1.6% on a QoQ basis from $886522.0 in Q4 2023.
Abvc Biopharma (ABVC) Convertible Debt (2018 - 2024) Analysis & Trends
Abvc Biopharma (ABVC) has 5 years of Convertible Debt data on file, last reported at $872336.0 in Q1 2024.
- Quarterly Convertible Debt rose 2661.69% year-over-year to $872336.0 in Q1 2024, while the trailing twelve-month figure through Mar 2024 was $872336.0 (up 2661.69% YoY) and the FY2023 annual result came in at $886522.0, changed N/A from the prior year.
- Convertible Debt eased to $872336.0 in Q1 2024, from $886522.0 in the prior quarter.
- In the past five years, Convertible Debt ranged from a high of $3.3 million in Q2 2023 to a low of $31587.0 in Q1 2023.
- A 4-year average of $1.8 million and a median of $2.1 million in 2020 frame the typical range for Convertible Debt.
- The widest YoY moves for Convertible Debt: up 2661.69% in 2024, down 2661.69% in 2024.
- Tracing ABVC's Convertible Debt over 4 years: stood at $2.5 million in 2020, then changed by 0.0% to $2.5 million in 2021, then sank by 64.54% to $886522.0 in 2023, then slipped by 1.6% to $872336.0 in 2024.
- The last three Convertible Debt figures came in at $872336.0 (Q1 2024), $886522.0 (Q4 2023), and $1.7 million (Q3 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Abvc Biopharma | 23.19 Mn | 23.19 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 872,336.00 |
| Dec 31, 2023 | 886,522.00 |
| Sep 30, 2023 | 1.65 Mn |
| Jun 30, 2023 | 3.30 Mn |
| Mar 31, 2023 | 31,587.00 |
| Jun 30, 2021 | 2.50 Mn |
| Mar 31, 2021 | 2.50 Mn |
| Dec 31, 2020 | 2.50 Mn |
| Sep 30, 2018 | 300,000.00 |
| Jun 30, 2018 | 300,000.00 |